Exact Sciences Total Revenue

Exact Sciences (EXAS) currently reports a total revenue of $3.2B as of December 2025. That compares with $2.8B in the prior-year period — up 17.7% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Exact Sciences's total revenue history and peer comparisons.

Exact Sciences's total revenue increased from $2.8B to $3.2B — a 17.7% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Exact Sciences's total revenue of $3.2B is lower than the Healthcare sector average of $110B. That is roughly 97.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Exact Sciences reported $3.2B in total revenue as of December 2025. That compares with $2.8B in the prior-year period — up 17.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $3.2B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Exact Sciences, and consider following EXAS for alerts when major investors trade the stock.